Literature DB >> 2368631

1 alpha,25-dihydroxyvitamin D3-induced increments in hepatocyte cytosolic calcium and lysophosphatidylinositol: inhibition by pertussis toxin and 1 beta,25-dihydroxyvitamin D3.

D T Baran1, A M Sorensen, T W Honeyman, R Ray, M F Holick.   

Abstract

1 alpha,25-Dihydroxyvitamin D3 rapidly increases cytosolic calcium and alters membrane phospholipid metabolism in hepatocytes. To define the causal relationship between these events, we examined the effects of 1 alpha,25-dihydroxyvitamin D3 on 32P-labeled lysophosphatidylinositol levels and cytosolic calcium as affected by pertussis toxin and 1 beta,25-dihydroxyvitamin D3, the biologically inactive analog. 32P-labeled lysophosphatidylinositol was determined by two-dimensional thin-layer chromatography. Cytosolic calcium was measured in cells loaded with quin-2AM. Within 5 min, 1 alpha,25-dihydroxyvitamin D3 increased hepatocyte cytosolic calcium by 31% (p less than 0.05) and 32P-labeled lysophosphatidylinositol by 38% (p less than 0.05). Pertussis toxin inhibited the hormone-induced rise in cytosolic calcium but not the increase in 32P-labeled lysophosphatidylinositol. Exposure to exogenous lysophosphatidylinositol for 5 min increased cytosolic calcium by 40% (p less than 0.05), an effect that was also inhibited by pertussis toxin. 1 beta,25-Dihydroxyvitamin D3 had no effect on either hepatocyte cytosolic calcium or 32P-labeled lysophosphatidylinositol but prevented the 1 alpha,25-dihydroxyvitamin D3-induced increments. The results suggest that a G protein sensitive to pertussis toxin is required for the transduction of the lysophosphatidylinositol signal but not the generation of the signal. The ability of 1 beta,25-dihydroxyvitamin D3 to inhibit the 1 alpha,25-dihydroxyvitamin D3-induced changes in phospholipids suggests that the epimer may compete with 1 alpha,25-dihydroxyvitamin D3 for an initiating receptor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2368631     DOI: 10.1002/jbmr.5650050514

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  4 in total

Review 1.  The nonskeletal effects of vitamin D: an Endocrine Society scientific statement.

Authors:  Clifford J Rosen; John S Adams; Daniel D Bikle; Dennis M Black; Marie B Demay; JoAnn E Manson; M Hassan Murad; Christopher S Kovacs
Journal:  Endocr Rev       Date:  2012-05-17       Impact factor: 19.871

2.  Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

Authors:  Whitney K Hendrickson; Richard Flavin; Julie L Kasperzyk; Michelangelo Fiorentino; Fang Fang; Rosina Lis; Christopher Fiore; Kathryn L Penney; Jing Ma; Philip W Kantoff; Meir J Stampfer; Massimo Loda; Lorelei A Mucci; Edward Giovannucci
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

3.  Generation of inositol phosphates, diacylglycerol and calcium fluxes in myoblasts treated with 1,25-dihydroxyvitamin D3.

Authors:  S Morelli; A R de Boland; R L Boland
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

Review 4.  Molecular link between vitamin D and cancer prevention.

Authors:  Meis Moukayed; William B Grant
Journal:  Nutrients       Date:  2013-09-30       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.